Vistagen's ph10 nasal spray demonstrates different mechanism of action from benzodiazepines in preclinical study

Ph10 may have stand-alone potential to displace current oral antidepressants in the drug treatment paradigm for depression disorders ph10 may have stand-alone potential to displace current oral antidepressants in the drug treatment paradigm for depression disorders
VTGN Ratings Summary
VTGN Quant Ranking